INSYS Therapeutics Completes Pharmacokinetics (PK) Study of Intranasal Naloxone for Opioid Overdose
Oct 03, 2017 14:07 pm UTC| Business
PHOENIX, Oct. 03, 2017 -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”), announced today that its recently completed pharmacokinetics (PK) study of the company’s proprietary intranasal naloxone spray...
Oct 03, 2017 14:07 pm UTC| Business
NEW YORK, Oct. 03, 2017 -- The Republic of Palau, EARTHx, and GridMarket are thrilled to announce that they have entered into a partnership to help Palau meet its energy goals, including achieving 45% renewable...
Oct 03, 2017 14:05 pm UTC| Business
AUSTIN, Texas, Oct. 03, 2017 -- The return of economic protectionism in the west and a race against the clock of North Korea’s nuclear ambitions will fuel primary geopolitical developments and trends in the...
eMARINE Global Announces Extension and Expansion of Contract with Korean Navy
Oct 03, 2017 14:01 pm UTC| Business
SEOUL, South Korea, Oct. 03, 2017 -- eMARINE Global, Inc. (OTC:EMRN), a leading provider of information and communications technology for the maritime industry, is pleased to announce it was awarded a maintenance...
Oct 03, 2017 14:00 pm UTC| Business
Forest Hill, MD, Oct. 03, 2017 -- On 19 September 2017 The Apache Software Foundation ("ASF") http://apache.org/ was contacted by the US House Committee on Energy and Commerce to answer questions in preparation for...
Zywave Releases Game-changing Tools for Brokers
Oct 03, 2017 14:00 pm UTC| Business
MILWAUKEE, Oct. 03, 2017 -- Today, Zywave announces the launch of both its Prospect Presentation Creator for insurance brokers and Health Plan Compliance Calendar for their clients. In the fourth round of enhancements...
DerivCon: Transforming SEFCON Pivoting from Adoption to Adaptation
Oct 03, 2017 14:00 pm UTC| Business
J. Christopher “Chris” Giancarlo To Open With Keynote New Event for Leaders in Swaps and Derivatives Markets Incorporates SEFCON NEW YORK, Oct. 03, 2017 -- TABB Group, the international research, advisory and...